Thyroid cancer trials in Germany

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

  Where

  Essen, Munich

  Age

  18 years to 100 years

  People

  116 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07006727 · EU 2024-519111-34-00
• Phase 2Taking people
  A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  Where

  Berlin, Frankfurt am Main, Heidelberg

  Age

  8 years and over

  People

  254 worldwide

  Run by

  Fore Biotherapeutics

  See details and how to joinNCT05503797 · EU 2024-513578-23-00
• Phase 1/2Taking people
  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Where

  Dresden, Heidelberg

  Age

  12 years and over

  People

  500 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT03093116 · EU 2024-512606-25-00
• No phaseTaking people
  Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

  Where

  Ulm

  People

  60

  Run by

  University of Ulm

  See details and how to joinNCT07410637